(MDVN:Consolidated Issue Listed on NASDAQ Global Select )
Pablo D. T. Valenzuela Ph.D.
Member of Scientific & Clinical Advisory Board, Medivation, Inc.
|Age||Total Calculated Compensation||This person is connected to 30 board members in 4 different organizations across 4 different industries.|
See Board Relationships
Dr. Pablo D.T. Valenzuela, Ph.D. is a Founder and President at Bios Chile. He is the Co-founder and Head of Research and Development of Grupo Bios, Austral Biologicals, Andes Bioscience, Ventra Bioscience, Fundación Ciencia Para la Vida, and at Chiron Corporation where he also served as the Senior Vice President, Biological Research and Development until 2000. He serves as a Director of Ventria Bioscience, Inc. Dr. Valenzuela serves as a Member of Scientific & Clinical ...
525 Market StreetPhone: 415-543-3470
San Francisco, California 94105
Board Members Memberships*
President of the Board
Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
University of California-San Francisco
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert H. Gundel Ph.D., M.B.A.||Chief Executive Officer, President, Director and Member of Financing Committee|
Amorfix Life Sciences Ltd.
|Michael L. Babich||Chief Executive Officer, President and Director|
INSYS Therapeutics, Inc.
|$1.0M||Compensation as of Fiscal Year 2013.|